SLC38A7 and cancer: Despite ASCT2 importance in T cell activation, some studies have shown that, in ASCT2-knockout mice, this amino acid transporter is not required for T and B cell development, B cell proliferation and antibody production, suggesting that the immune system of cancer patients might tolerate the inhibition of this transporter [67,72].